Lanean...

The clinical use of biomarkers as prognostic factors in Ewing sarcoma

Ewing Sarcoma is the second most common primary bone sarcoma with 900 new diagnoses per year in Europe (EU27). It has a poor survival rate in the face of metastatic disease, with no more than 10% survival of the 35% who develop recurrence. Despite the remaining majority having localised disease, app...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: van Maldegem, Annmeik M, Hogendoorn, Pancras CW, Hassan, Andrew B
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3351700/
https://ncbi.nlm.nih.gov/pubmed/22587879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-3329-2-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!